Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Hangzhou DAC Biotech Co., Ltd
company
About
Hangzhou DAC Biotech Co., Ltd focuses on developing conjugate of monoclonal antibody and small molecular cytotoxic drugs.
- 101 - 250
Details
- Last Funding Type
- Seed
- Last Funding Money Raised
- ¥1M
- Industries
- Biotechnology,Health Care,Medical
- Founded date
- Dec 31, 2012
- Number Of Employee
- 101 - 250
- Operating Status
- Active
Funding Rounds
Number of Funding Rounds
Total Funding Amount
4
¥1.07B
Hangzhou DAC Biotech Co., Ltd has raised a total of
¥1.07B
in funding over 2 rounds. Their latest funding was raised on
May 12, 2021 from a Series C round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 12, 2021 | Series C | ¥1B | 2 | — | — | Detail |
| Jan 12, 2018 | Series B | ¥20M | 1 | — | — | Detail |
| May 26, 2017 | Series A | ¥50M | 1 |
|
— | Detail |
| Oct 22, 2013 | Seed | ¥1M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
1
5
Hangzhou DAC Biotech Co., Ltd is funded by 5 investors.
Huahai Yaoye
and Kwai Hung Group
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
Yes | Series A |
|
|
— | Series C |
Tigeryeah Capital
|
— | Series C |
|
|
— | Series B |
|
|
— | Seed |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
